The Medicines and Healthcare products Regulatory Agency (MHRA) granted marketing authorisation for Mounjaro, a new therapy, to treat type 2 diabetes in adults. This decision comes after encouraging results from clinical trials that showed Mounjaro significantly reduces blood sugar levels in patients. Mounjaro functions as a once-weekly injection t